Anti-inflammatory Composition with Specific Benzene Ring Structure

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current anti-inflammatory compositions for skin inflammation, such as those for atopic dermatitis, often have temporary effects and cause side effects like skin irritation, and natural extracts face limitations due to solubility issues and skin irritation, making them ineffective for substantial application.

Innovation Solution

An anti-inflammatory composition containing a specific compound represented by Chemical Formula 1, which inhibits the production of inflammation-inducing cytokines like IL-8 and IL-17, promoting skin regeneration and barrier recovery without cytotoxicity or skin irritation, is developed.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If synthetic medicines such as ibuprofen, steroids, and immunosuppressants are used for treatment, then anti-inflammatory effect is achieved, but side effects such as skin irritation, hypersensitivity reaction, and immune system aggravation occur

Engineering Contradiction:
Improveanti-inflammatory effectVSAvoidskin irritation and side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical structure parameters by introducing specific functional groups (amino group at position 2, carboxyl group at position 3, and hydroxyl group at position 4 on the benzene ring) to create a novel compound that maintains anti-inflammatory efficacy while eliminating harmful side effects associated with conventional synthetic medicines

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent combines multiple functional groups (amino, carboxyl, and hydroxyl groups) on a benzene ring structure to create a composite molecular structure that achieves both therapeutic effect and safety, resolving the contradiction between efficacy and side effects

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If natural extracts are used for anti-inflammatory treatment, then safety is improved, but solubility in water is poor and skin irritation still occurs, limiting application effectiveness

Engineering Contradiction:
Improvesafety profileVSAvoidsolubility and application effectiveness
Core Design Contradiction:
Object-affected harmful factorsVSEase of operation

Solution Approach 1:

The patent modifies the molecular parameters by introducing polar functional groups (carboxyl and hydroxyl groups) that enhance water solubility while maintaining the safety profile of natural extracts, thereby improving ease of application and effectiveness

Inventive Principle:
Principle #35Parameter changes

3Duration of action of moving object

If existing cosmetic compositions are applied to achieve anti-inflammatory effect, then some symptom relief is obtained, but the effect is temporary and substantial treatment is difficult due to limitations in application and solubility

Engineering Contradiction:
Improveduration of anti-inflammatory effectVSAvoidapplication limitation
Core Design Contradiction:
Duration of action of moving objectVSEase of operation

Solution Approach 1:

The patent changes the solubility parameters by introducing polar functional groups that enable better water solubility, allowing for effective application and sustained presence on the skin, thereby extending the duration of anti-inflammatory effect and overcoming application limitations

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS11351131B2Anti-inflammatory composition
Publication Date: 2022.06.07 NEOPHARM CO LTD
  • US11351131B2 patent drawing
  • US11351131B2 patent drawing
  • US11351131B2 patent drawing

AI summary

An anti-inflammatory composition is disclosed. The anti-inflammatory composition is useful for a pharmaceutical composition or a cosmetic composition by not only having excellent stability on the skin and therefore being harmless to the human body, but also by controlling the expression of an inflammatory skin disease-related mediating factor and thereby exhibiting an excellent anti-inflammatory effect.